Leukemia, Myeloid  >>  GEM 640  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GEM 640 / Pharmascience
NCT00363974: Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

Completed
1/2
54
US, Canada
XIAP antisense
Aegera Therapeutics
Leukemia, Myelomonocytic, Acute
03/09
03/09

Download Options